Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas
Clinical trial NCT03188328 · TERMINATED
Trial details
- NCT number
- NCT03188328
- Sponsor
- Alfasigma S.p.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2019-06-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.